ZTOX

Market Updates Earnings conference call

Marksans Pharma Q4 FY 26 Earnings Call Transcript Now on NSE

Marksans Pharma has published the transcript of its Q4 FY 26 earnings conference call with analysts on NSE, covering the company's audited financial results for the quarter.

Market Updates Earnings conference call

Marksans Pharma Q4 FY26 Analyst Call Transcript Published on NSE

Marksans Pharma has made its Q4 FY26 investor call transcript available via NSE filing. The document covers the audited financial results presentation to analysts and institutional investors.

Market Updates Earnings conference call

Marksans Pharma (MARKSANS): Analysts/Institutional Investor Meet/Con. Call Updates

Analysts/Institutional Investor Meet/Con. Call Updates Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchang

Market Updates Corporate announcement

Marksans Pharma Urges Shareholders for KYC Updates Ahead of IEPF Transfer

Marksans Pharma has initiated a shareholder engagement campaign urging investors to complete KYC updations and claim pending dividends before these are transferred to the Investor Education and Protection Fund (IEPF).

Market Updates Corporate announcement

Marksans Pharma (MARKSANS): Company Update

Company Update Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF

Market Updates Corporate announcement

Marksans Pharma (MARKSANS): Press Release

Press Release Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange reg